Development of a Monitoring and Evaluation Framework for the
Implementation of Elimination of Viral Hepatitis
GEOGRAPHIC REACH: Global
PARTNER: Division of Infectious Diseases Columbia University in the City of New York.
The project has been designed to develop and implement a monitoring and evaluation framework, which specifically addresses issues and challenges unique to the implementation of action plans to eliminate viral hepatitis as a global health threat.
The WHO Health Sector Strategy indicators suggest that the goal of viral hepatitis elimination will be achieved if more than 7 million new hepatitis B and C infections are averted and related mortality is reduced to less than 500,000 deaths by 2030. In 2019, EndHep2030 issued a call for proposals in support of this global initiative to eliminate viral hepatitis. Projects were selected for their innovative approaches to inform evidence based policy formulation, to overcome systemic barriers, and to strengthen service delivery by scaling up proven interventions. EndHep2030 aims to accelerate planning and implementation at national and regional levels.
The Global Health Services Delivery programme at the Columbia University Division of Infectious Diseases was selected to design a M&E framework for The Hepatitis Fund’s grants programme and to provide training to the grant recipients.
EndHep2030’s contribution towards hepatitis elimination will be measured through a cohesive and consistent M&E approach that helps define and measure catalytic program inputs, outputs and outcomes.
The EndHep2030 M&E framework details the key components of EndHep2030’s strategic approach to assess catalytic impact and forms the foundation for EndHep2030’s monitoring and evaluation plan. The EndHep2030 M&E framework will be further enhanced through the input from grantees and be shared with the broader hepatitis community.
The pathway to catalytic impact includes assessing if achievement of targets would have been attained at the same time or scaled had the program not been implemented. Catalytic impact is expected to be multifold, sustained, and lasting.
The creation and application of a framework to monitor and evaluate the performance of the EndHep2030 portfolio will be critical to enable real-time learning and mitigate the impact of force majeure events (such as disruptions brought about by a global pandemic).
Lessons learned and knowledge accumulated can be valuable contributions to the global campaign to eliminate viral hepatitis in the foreseeable future.
The EndHep2030 M&E framework is a tool for systematically monitoring funded projects for catalytic impact, and at the same creating a community of learning and sharing for capacity building.
EndHep2030 will assess the overall contribution of this program strategy to eliminating viral hepatitis through cycles of funding in consultation with various stakeholders and field experts.
Monitoring and evaluation of EndHep2030 grants will be a critical part of explaining – if, how and why catalytic projects contributed to The Hepatitis Fund’s mission of eliminating viral hepatitis as a global health threat.